Trademark Overview
On Wednesday, July 8, 2026, a trademark application was filed for NASHNEXT with the United States Patent and Trademark Office. The USPTO has given the NASHNEXT trademark a serial number of 99928857. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 8, 2026. This trademark is owned by GENFIT. The NASHNEXT trademark is filed in the Pharmaceutical Products category with the following description:
Diagnostic preparations for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic biomarkers for in vitro testing for medical use; Medical diagnostic reagents for the analysis of body fluids; Reagents for use in the detection, diagnosis, prognosis and monitoring of liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Reagents and diagnostic tests for screening and stratification of patients at risk of liver diseases and metabolic disorders; Medical diagnostic test in the form of algorithm-based blood test for identifying patients with liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH)
